- Justice Department takes ‘major step’ toward rescheduling marijuana (nbcnews.com)
The Justice Department took a significant step toward rescheduling marijuana Thursday, formalizing its process to reclassify the drug as lower-risk and remove it from a category in which it has been treated as more dangerous than fentanyl and meth...President Joe Biden announced the “major” move in a direct-to-camera video posted to his official account on X. “This is monumental,” Biden said in the message. “It’s an important move towards reversing long-standing inequities. … Far too many lives have been upended because of a failed approach to marijuana, and I’m committed to righting those wrongs. You have my word on it.”...The Biden administration has been signaling that it would move to reschedule the drug from Schedule I — a strict classification including drugs like heroin — to the less-stringent Schedule III, which would for the first time acknowledge the drug’s medical benefits at the federal level. The Drug Enforcement Administration submitted a notice of proposed rulemaking in the Federal Register on Thursday afternoon, triggering a 60-day comment period that will allow members of the public to submit remarks regarding the rescheduling proposal before it is finalized...READ MORE
- HHS recommended that the DEA make kratom a Schedule I drug, like LSD or heroin (statnews.com)
The Department of Health and Human Services has recommended a ban on the chemicals in kratom that would make the popular herbal supplement as illegal as heroin or LSD…HHS asserted in a letter to the Drug Enforcement Administration that two chemicals in kratom should be classified as Schedule I substances... FDA...has said that kratom is “an opioid” and has been “associated” with dozens of deaths...Kratom should not be used to treat medical conditions, nor should it be used as an alternative to prescription opioids...Some states have already banned kratom, but it’s currently legal at the federal level. It’s sold in different forms, including dry powder and capsules. According to the American Kratom Association, millions of Americans use the substance.
- DEA, Dutch law enforcement continue attack on dark web drug sales (dea.gov)
The United States Drug Enforcement Administration and Dutch law enforcement officials...announced sustained action against drug trafficking on the dark web, following last summer’s significant market takedowns of AlphaBay and takeover and subsequent takedown of the Hansa market. DEA continued to partner with the National Police of the Netherlands...to identify individuals who purchase drugs on the dark web and to further disrupt dangerous drug trafficking. Further examination of the Hansa Market data revealed illicit drug purchase information identifying U.S. and Dutch individuals, resulting in numerous face-to-face doorstep visits by police to suspected opioid buyers throughout the U.S. and the Netherlands...AlphaBay operated as a hidden service on the “Tor” network, and utilized cryptocurrencies including Bitcoin, Monero and Ethereum in order to hide the locations of its underlying servers and the identities of its administrators, moderators, and users. Based on law enforcement’s investigation of AlphaBay, authorities believe the site was also used to launder hundreds of millions of dollars deriving from illegal transactions on the website...the Hansa Market, another prominent dark web market...was used to facilitate the sale of illegal drugs, toxic chemicals, malware, counterfeit identification documents, and illegal services. The administrators of Hansa Market, along with its thousands of vendors and users, also attempted to mask their identities to avoid prosecution through the use of Tor and digital currency.
- The government’s struggle to hold opioid manufacturers accountable (washingtonpost.com)
Sixty-six percent of all oxycodone sold in Florida came from this company. But the DEA’s case against it faltered...Mallinckrodt’s blue 30-milligram oxycodone tablets became so popular among drug users and dealers that they acquired a street name — "M’s," for the company’s distinctive block-letter logo…the Drug Enforcement Administration trained its sights in 2011 on Mallinckrodt Pharmaceuticals, one of the nation’s largest manufacturers of the highly addictive generic painkiller oxycodone. ..It was the first time the DEA had targeted a manufacturer of opioids for alleged violations of laws designed to prevent diversion of legal narcotics to the black market. And it would become the largest prescription-drug case the agency has pursued…But six years later, after four investigations that spanned five states, the government has taken no legal action against Mallinckrodt. Instead, the company has reached a tentative settlement with federal prosecutors…Under the proposal…Mallinckrodt would agree to pay a $35 million fine and admit no wrongdoing.
- Big drug distributor pays $22 million to settle U.S. opioid charges (reuters.com)
Morris & Dickson Co, one of the largest U.S. wholesale drug distributors, agreed to pay $22 million in civil penalties to settle U.S. government charges that it failed to report thousands of suspicious orders of the opioids hydrocodone and oxycodone...The...Louisiana-based company will also spend millions of dollars to hire staff and upgrade oversight to help comply with federal regulations requiring that orders be properly reported...Drug Enforcement Administration...since...2014 uncovered more than 12,000 retail pharmacy orders for hydrocodone and oxycodone that Morris & Dickson should have flagged to that agency...READ MORE
- U.S. judge blocks DEA from suspending drug distributor over opioid sales (reuters.com)
A federal judge blocked the U.S. Drug Enforcement Administration from suspending a Louisiana drug distributor from selling controlled substances over allegations it failed to identify suspicious orders of opioids that were diverted for illicit uses...U.S. District Judge Elizabeth Foote in Shreveport, Louisiana, on Tuesday entered a temporary restraining order blocking the DEA from enforcing an order issued last week that immediately suspended Morris & Dickson Co’s registration...The DEA’s order marked the first time during President Donald Trump’s administration that it had moved to immediately block narcotic sales by a distributor as the agency attempts to combat a national opioid abuse epidemic...The DEA on Friday announced it was suspending the registration of privately-held Morris & Dickson, saying the distributor failed to properly identify large, suspicious orders of drugs sold to independent pharmacies.
- DEA proposes cutting production of some opioid painkillers (reuters.com)
The Drug Enforcement Administration...proposed a 20 percent reduction in the manufacture of certain commonly prescribed opioid painkillers as well as other controlled substances for next year...The proposal comes as U.S. regulators and lawmakers take steps to limit the supply of opioids - a class of drugs that include prescription painkillers and heroin - to combat the epidemic of abuse, overdose and addiction...The DEA's proposed production quotas for Schedule I and II substances reflect the amount needed to meet the United States' medical, scientific, industrial, export and reserve requirements...The DEA recommendation comes about two months after the Food and Drug Administration took the rare step of asking a drugmaker (Endo International) to withdraw its opioid painkiller from the market, citing the public health crisis.
- Study links opioid epidemic to painkiller marketing (reuters.com)Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses (jamanetwork.com)
Researchers are reporting a link between doctor-targeted marketing of opioid products and the increase in U.S. deaths from overdoses...In a county-by-county analysis, they found that when drug companies increased their opioid marketing budgets by just $5.29 per 1,000 population, the number of opioid prescriptions written by doctors went up by 82 percent and the opioid death rate was 9 percent higher a year later...“It really doesn’t take much marketing to increase the number of deaths,” lead author Dr. Scott Hadland...Jordan Trecki of the U.S. Drug Enforcement Administration warns that the new analysis only addresses part of the problem...“As the opioid epidemic grows, it is evolving beyond prescription medications and heroin to involve illicitly produced fentanyl, fentanyl-related substances and other opioids, either alone or in combination,”...
- U.S. drug agency suspends Louisiana distributor over opioid sales (reuters.com)
...Drug Enforcement Administration said...it had suspended a Louisiana pharmaceutical distributor from selling controlled substances for allegedly selling unusually large quantities of opioids to pharmacies without reporting the sales...Morris & Dickson Co...investigation showed “it failed to properly identify large suspicious orders for controlled substances sold to independent pharmacies with questionable need for the drugs.”...Morris & Dickson filed in federal court...an injunction against the suspension, and U.S. District Judge Elizabeth Foote in Shreveport has scheduled a hearing...on its request for a temporary restraining order...The probe, which focused on purchases of Oxycodone and Hydrocodone, showed that in some cases, pharmacies were allowed to buy as much as six times the quantity of narcotics they would normally order...
- Ex-New York assemblyman, doctors charged in illegal opioid prescription scheme: officials (reuters.com)
A former New York assemblyman and a dozen pain clinic workers were arrested on Friday, accused of operating some of the largest "pill mills" in the northeastern United States and illegally prescribing more than 6 million opioid pills...Alec Brook-Krasny, who served in the New York State Assembly from 2006 to 2015 representing South Brooklyn, was charged with conspiracy and scheming to defraud by unlawfully selling prescriptions…Also arrested in the sweep of three pain clinics were at least one nurse practitioner, three physician's assistants, and two doctors including Dr. Lazar Feygin, who owned two of the clinics...They were accused of over-prescribing oxycodone...to clinic patients who showed signs of selling pills or abusing other narcotics...in exchange for oxycodone, the defendants also pressured patients to undergo unnecessary medical tests and procedures, then billed Medicare and Medicaid for millions of dollars...